Koers NeuroScientific Biopharmaceuticals Limited
Aandelen
NSB
AU0000012973
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,048 AUD | -7,69% | -18,64% | +9,09% |
Omzet 2022 | - | Omzet 2023 | 4,95 mln. 3,24 mln. 3,03 mln. | Marktkapitalisatie | 11,48 mln. 7,5 mln. 7,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -10 mln. -6,53 mln. -6,11 mln. | Nettowinst (verlies) 2023 | -1 mln. -653K -611K | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 7,22 mln. 4,71 mln. 4,41 mln. | Nettoliquiditeiten 2023 | 4,91 mln. 3,21 mln. 3 mln. | EV/omzet 2023 | 1,33 x |
K/w-verhouding 2022 |
-2,47
x | K/w-verhouding 2023 |
-10,7
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 65,16% |
1 dag | -7,69% | ||
1 week | -18,64% | ||
Lopende maand | +2,13% | ||
1 maand | +6,67% | ||
3 maanden | +37,14% | ||
6 maanden | -20,00% | ||
Lopend jaar | +9,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Dougal Thring
COO | Chief Operating Officer | - | 31-03-21 |
Anton Uvarov
BRD | Director/Board Member | - | 29-09-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 29-09-17 |
Chairman | - | 17/11 | |
Tony Keating
BRD | Director/Board Member | - | 05/12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,048 | -7,69% | 377 703 |
24-04-24 | 0,052 | -1,89% | 128 144 |
23-04-24 | 0,053 | +1,92% | 188 602 |
22-04-24 | 0,052 | -1,89% | 67 124 |
19-04-24 | 0,053 | -10,17% | 1 432 994 |
uitgestelde koers Australian S.E., 26 april 2024 om 07:36 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+9,09% | 4,89 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |